MedPath

A study of Outcome, Quality of Life and Satisfaction in women after breast reconstruction.

Conditions
Breast cancer, (preventive) mastectomy, BRCA gene mutation, Breast reconstruction, autologous reconstruction, alloplastic reconstruction.Borstreconstructie, (preventieve) ablatio, , BRCA gen mutatie, autologe reconstructie, alloplastische reconstructie
Registration Number
NL-OMON22225
Lead Sponsor
niverity Medical Centre Groningen
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
116
Inclusion Criteria

1. Women who have/had breast cancer and need(ed) a mastectomy and will undergo a breast reconstruction;

2. Women with BRCA gene mutation, who undergo a preventive mastectomy and want their breasts primarily reconstructed;

Exclusion Criteria

1. Women who do not understand the Dutch language well;

2. Women who are illiterate in reading and/or writing;

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary outcome measure is the Quality of Life as measured with the Breast Q.
Secondary Outcome Measures
NameTimeMethod
1. Health related Quality of Life as measured by the Rand 36;<br /><br>2. The fear for recurrence of cancer on the QoL of the breast cancer patients as measured by the CARS;<br /><br>3. Anxiety and Depression as measured by the HADS;<br /><br>4. Cosmetic outcome as measured by the Strasser Score and the POSAS.
© Copyright 2025. All Rights Reserved by MedPath